Viewing Study NCT03159702

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 3:47 AM
Ignite Modification Date: 2026-03-02 @ 5:53 PM
Study NCT ID: NCT03159702
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-01-24
First Post: 2017-05-17
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Propylene Glycol-Free Melphalan HCl (EVOMELA®) in Combination With Fludarabine and Total Body Irradiation Based Reduced Intensity Conditioning for Haploidentical Transplantation
Sponsor: Medical College of Wisconsin
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Hematological Malignancy View
None Multiple Myeloma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None hematological malignancy View
None EVOMELA View
None Melphalan HCl View
None Total Body Irradiation View
None Reduced Intensity Conditioning View
None Haploidentical Transplantation View
None Fludarabine View
None Hematologic Diseases View